Open Access 
              
Copyright: The authors. This article is an open access 
article licensed under the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/2.0) which permits unrestricted use, 
distribution and reproduction in any medium, provided the work is properly 
cited.
              
              
                            
                            
                            
                            Original Research
                            
                            5. 
                            
                            Studies on the duration of immunity induced in 
                            cattle after natural FMD infection and post 
                            vaccination with bivalent oil vaccine - Ehab El-Sayed, Wael Mossad, Samir Mohamed Ali, 
                            Mohamed Shawky
                            Vet World. 2012; 5(10): 603-608
              
               
              
              doi: 
              10.5455/vetworld.2012.
603-608
              
              
               
              
              
              
   
 
              
               
               
               
              
              
              Abstract
              
                            
                            Aim: 
                            To detect the proper time for vaccination of 
                            infected calves after the onset of clinical signs 
                            and revaccination for previously vaccinated animals 
                            with bivalent FMD montanide ISA206 inactivated 
                            vaccine. Materials and Methods: Twenty calves 
                            naturally infected with foot and mouth disease (FMD) 
                            showing clinical signs represented by lesions on the 
                            tongue, buccal mucosa and feet. Samples were 
                            collected from these calves including tongue 
                            epithelial and oropharyngeal fluid (OP). The 
                            causative virus was isolated from such samples 
                            through inoculation of baby mice and typed by 
                            indirect Sandwich ELISA and was confirmed in 2 
                            tongue epithelia samples using PCR. 
                            
                             Results: 
                            The serum antibody titers were determined using SNT 
                            and ELISA in the sera of the 20 infected calves 
                            revealing that the infected farms should be 
                            vaccinated with inactivated bivalent FMD vaccine for 
                            (type O and A) Adjuvanted with montanide ISA206 
                            after 32 weeks from the appearance of clinical 
                            signs. In addition the FMD immune status was 
                            monitored in 2 farms in EL-Fayoum and El-Sharkia 
                            Governorates where 50 calves in each farm were 
                            vaccinated with the bivalent FMD inactivated vaccine 
                            adjuvaned with montanide ISA206 and serum samples 
                            were collected monthly from these animals to 
                            determine their immune status using SNT and ELISA. 
                            The obtained results showed that vaccinated calves 
                            with the bivalent FMD montanide ISA206 inactivated 
                            vaccine should be revaccinated after 36 weeks post 
                            vaccination. 
                            
                             Conclusions: naturally infected 
                            calves should be vaccinated on the 32 weeks post 
                            infection while vaccinated calves should be 
                            revaccinated on the 36 weeks post vaccination. 
                            
                             
                            Keywords: bivalent montanide ISA 206 vaccine, 
                            ELISA, Foot and Mouth disease, infection, SNT, 
                            vaccination